The Micheline Wentworth Fund for Ovarian Cancer Research has been created to honor the life of its namesake, recognizing her determined, optimistic, and tireless fight against the disease that took her life. We are asking Triathletes to honor her spirit, one that is exemplified in the Triathlon, by raising money in their multisport endeavors (Sprint through Ironman!) to help research early detection techniques and create better screening procedures.
Over 22,000 women are diagnosed with ovarian cancer in the United States each year. Unfortunately, most are not diagnosed until they are in the advanced stages of the disease. Though great strides have been made in its treatment, over 14,000 U.S. women die from ovarian cancer every year.
Micheline’s research fund will assist scientists at the Barbara Ann Karmanos Cancer Institute in developing more effective screening and early detection of ovarian cancer. The research will facilitate the administration of therapies at more treatable stages and support the development of novel therapies, such as targeted therapeutics. Lastly, the fund will assist in the establishment of a registry of genetic information unique to ovarian cancer. Micheline’s hope was that this fund will make significant contributions to discovering a cure for ovarian cancer.
The Micheline Wentworth Fund for Ovarian Cancer Research will be supervised by the Barbara Ann Karmanos Cancer Institute, overseen by the Director of Gynecologic Oncology, Dr. Robert T. Morris.
We would invite Triathletes/Runners/Walkers competing in ANY race to join the fight.
Thank you from the bottom of our hearts!
Chantal Wentworth-Mullin & Danielle M. Haynes